Authors


Donald M. Hilty, MD

Latest:

Drug Therapies for the Neurobehavioral Sequelae of Traumatic Brain Injury

Traumatic brain injury (TBI) is one of the most common causes of morbidity and mortality, especially in young adults. Recognition and early accurate diagnosis of neurobehavioral TBI sequelae are important in reducing the severity of postinjury symptoms. Sequelae of TBI include cognitive impairments, personality changes, aggression, impulsivity, apathy, anxiety, depression, mania, and psychosis.


Donald Olson, MD

Latest:

Differentiating Epileptic Seizures From Other Spells

It can be difficult to determine whether unusual, paroxysmal behavior represents a seizure or a nonepileptic event. Patients with convulsive, clonic movements may, in fact, be experiencing psychogenic events.


Donald W. Black, MD

Latest:

Psychiatric Comorbidity Associated With Pathological Gambling

Gambling has become a major recreational activity in the United States. Formerly confined to a few states such as Nevada and New Jersey, legal gambling opportunities have exploded across the nation in the past 2 decades.


Donna A. Wirshing, MD

Latest:

Treatment Challenges in Schizophrenia: A Multifaceted Approach to Relapse Prevention

While an antipsychotic medication is the first step of treatment for schizophrenia, it is increasingly recognized that comprehensive care requires the integration of adjunctive therapies and attention to long-term treatment goals.


Donna M. Norris, MD

Latest:

6 Things to Remember When Practicing Telemedicine

What 6 things are important to keep telemedicine practice running smoothly?


Donna M. Sudak, MD

Latest:

Psychotherapy for Treatment-Resistant Depression Is Overlooked, Underused

"Evidence indicates that psychotherapy may yield greater durability of treatment gains than pharmacotherapy."


Donna Wirshing, MD

Latest:

Medicolegal Considerations in the Treatment of Psychosis With Second-Generation Antipsychotics

Are the metabolic side effects of the atypical antipsychotics fueling the next round of malpractice suits being filed against psychiatrists? Guidelines are being created, but how can clinicians protect themselves and their patients, while continuing to give their patients the best care available?


Dora Black, MD

Latest:

Coping When Mother Kills Father

In almost all cases where the mother kills the father, the mother has endured years of abuse at the hands of the father. Unfortunately, the children also suffer. How can psychiatrists help these children heal after such a tragedy?


Doriana Morar, MD

Latest:

Insights Into Mood and Cognitive Disability in MS: Recognition and Treatment

Depression and cognitive impairment are common in patients with multiple sclerosis (MS) but often are overlooked. These complications affect not only general quality of life but also complicate core symptoms of the disease. Depression in MS is well documented and easily treated while cognitive impairment sometimes needs a sharper eye to detect.


Doris Greenberg, MD

Latest:

Asperger Disorder: Gone But Not Forgotten

Although Asperger disorder is now included as part of the overall autism spectrum disorder, some say Pandora’s box has been opened.


Doris Iarovici, MD

Latest:

Perspectives on College Student Suicide

Loneliness, substance abuse, dating violence, and hopelessness, are just some of the risk factors for suicide, which remains the second leading cause of death for college students.


Doron Sagman, MD

Latest:

Comorbidity in Bipolar Disorder

The central tenet of clinical comorbidity, the occurrence of 2 syndromes in the same patient, presupposes that they are distinct categorical entities.


Dorothy P. Reddy, MD

Latest:

Treatment-Resistant Anxiety Disorders: Neurotrophic Perspectives

Anxiety disorders are the most prevalent psychiatric disorders in the United States. Although effective treatments are available, such as the SSRIs and cognitive-behavioral therapy (CBT), it is estimated that in about 40% of patients, anxiety disorders are partially or completely resistant to first-line treatment.


Dorothy Stubbe

Latest:

Child and Adolescent Psychiatry

One of the major challenges in child psychiatry is teaching the essentials of the field to the general physician or medical school student who needs some understanding of developmental issues and psychopathology. Dorothy Stubbe's contribution to this challenge is a small and well-written handbook published as part of the series, Practical Guides in Psychiatry.


Doug Berger, MD, PhD

Latest:

Cognitive Behavioral Therapy: Escape From the Binds of Tight Methodology

CBT has become rooted as proven dogma in the treatment of depression despite large problems remaining in methodology of CBT clinical trials and the logic behind how CBT works. This article will describe the major methodologic problems in the clinical trials of CBT.


Doug Drossman, MD

Latest:

Functional GI Disorders and Psychiatry

This article provides background information on the FGIDs for psychiatrists and a review of recent research on the biopsychosocial mechanisms that contribute to the illness experience.


Doug Puryear, MD

Latest:

An Alternative Approach To The Suicidal Patient: Crisis Intervention

There are currently several disturbing phenomena in the field of suicidology: •Many papers are describing risk assessment and suggesting the need for high-risk patients to be hospitalized. •Emergency department (ED) staff are complaining about spending much of their time trying to find beds for patients. •Programs are claiming “crisis intervention” when, in fact, they only provide triage.


Douglas A. Kramer, MD, MS

Latest:

Remembering: A Gentleman and a Psychiatrist

Johan Verhulst, MD, left this world exactly as he lived-with grace, honor, integrity, humor, love, humility, intellect, and a continuing interest in our ongoing professional conversations.


Douglas H. Hughes, MD

Latest:

Psychiatry and Chronic Pain

Although acute pain typically resolves on its own with little need for intervention, for some persons pain persists past the point where it is considered an adaptive reaction to injury.


Douglas H. Ingram, MD

Latest:

Who Was Karen Horney?

Knowing from the start how a personality is organized, especially as theorized by Karen Horney-appreciating the primary and repressed moves of the patient, inner dictates, claims, idealized image, and intrapsychic defensive maneuvers-makes the help we offer most likely to succeed.


Douglas L. Noordsy, MD

Latest:

Comorbid Schizophrenia and Substance Use-Moving Toward Improved Functional Outcomes

Pharmacological and nonpharmacological strategies to treat and manage comorbid schizophrenia and addiction concern psychiatrists who are learning strategies to help improve functional outcomes.


Douglas Noordsy, MD

Latest:

Advances in Schizophrenia in 2016

The year 2016 marks a critical time in our understanding of and approaches to treating schizophrenia spectrum disorders.


Douglas Turkington, MD

Latest:

The ABCs of Cognitive-Behavioral Therapy for Schizophrenia

This article examines the use of cognitive-behavioral therapy for psychosis, the evidence for its use, and the implications for practicing psychiatrists given the short-comings of pharmacologic therapy.


Douglas W. Scharre, MD

Latest:

The Complex Interaction of Cognitive Issues

Cognitive impairment is a common symptom in many psychiatric and neurologic conditions. The articles selected for this Psychiatric Times special report provide a sampling of some important and topical issues regarding the influence of various factors on cognition in individuals with neuropsychiatric conditions.


Duane D. H. Pitt, MD

Latest:

Strategies for Treating Osteoporosis and Its Neurologic Complications

Osteoporosis is a disorder characterized by low bone mass and microarchitectural deterioration with resulting compromised bone strength and increased risk of fracture.1 The World Health Organization defines osteoporosis based on T-scores, which reflect bone mineral density (BMD) relative to mean BMD for healthy 25-year-old same-sex populations. A T-score between 0 and 21 is considered normal density, a score between 21 and 22.5 indicates osteopenia, and a score of less than 22.5 signifies osteoporosis.2 Severe osteoporosis is defined as a T-score of less than 22.5 combined with a fragility fracture.2


Duane M. Chase, MD

Latest:

Culture and Substance Abuse: Impact of Culture Affects Approach to Treatment

There have been numerous definitions of culture. Dwight Heath1 offers a simple definition: "It [culture] is a system of patterns of belief and behavior that shape the worldview of the member of a society. As such, it serves as a guide for action, a cognitive map, and a grammar for behavior."


Duncan B. Clark, MD, PhD

Latest:

Treating Adolescents With Major Depression and an Alcohol Use Disorder

Alcohol is the drug of choice for adolescents, with cigarettes and marijuana being second and third. Contrary to widespread belief, alcohol dependence is most common in 18- to 20-year-olds, with progressively decreasing rates of alcohol dependence in older age groups.


Duncan Maccourt, MD

Latest:

Caught in Limbo Between Law and Psychiatry

The case of dentist Charles Sell, who suffers from delusional disorder, still awaits resolution. In the meantime, Sell remains incarcerated while his competency to stand trial is debated. Does this serve justice?


Dushyant Viswanathan, MD

Latest:

Working With Patients on a Noninvasive Alternative to Surgery

A comprehensive treatment plan is a systematic, thorough, painstaking therapeutic program that takes time for implementation and results


Dwayne Timothy Coon, PhD

Latest:

Adaptation and Implementation of the Integrated Dual Diagnosis Treatment Model Into a Psychiatric Inpatient Facility: A 12-Year Perspective

As early as the 1970s, researchers and practitioners became increasingly aware of the necessity for services that would address the varied needs and treatment implications for consumers with the co-occurring disorders of substance abuse and mental illness. High percentages of consumers in substance abuse treatment centers were identified with mental illness disorders, and consumers admitted to psychiatric facilities often were identified as having additional substance use disorders.

© 2025 MJH Life Sciences

All rights reserved.